Trials / Unknown
UnknownNCT05913310
Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia
A Randomized Controlled Study of Kui-Yuan Chewable Tablets in the Treatment of Hyperuricemia
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 126 (estimated)
- Sponsor
- Quan Jiang · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a multi-center, randomized, double-blinded, controlled trial with two parallel arms. The aim of the study is to evaluate efficacy and safety of Kui-Yuan chewable tablets in patients with hyperuricemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Kui-Yuan Chewable Tablets | Kui-Yuan chewable tablets are the optimal ingredients found in sunflower dish that can reduce uric acid and anti-gout, including flavonoids, Coumarin (including scopolamine) and phenolic acids. |
| DRUG | Placedo of Kui-Yuan Chewable Tablets | Placedo of Kui-Yuan Chewable Tablets are composed of L-arabinose, food starch and a few auxiliary materials. |
Timeline
- Start date
- 2023-07-01
- Primary completion
- 2024-07-01
- Completion
- 2024-08-01
- First posted
- 2023-06-22
- Last updated
- 2023-06-22
Source: ClinicalTrials.gov record NCT05913310. Inclusion in this directory is not an endorsement.